Ra Capital Management, L.P. Ascendis Pharma A/S Put Options Transaction History
Ra Capital Management, L.P.
- $4.58 Billion
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ASND
# of Institutions
276Shares Held
60MCall Options Held
217KPut Options Held
73.3K-
Westfield Capital Management CO LP Boston, MA5.48MShares$1.12 Billion4.42% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.98MShares$1.02 Billion15.67% of portfolio
-
Janus Henderson Group PLC London, X04.43MShares$903 Million0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.26MShares$869 Million1.14% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.58MShares$731 Million0.39% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $11.4B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...